However, in March 2025, Soleno Therapeutics marked a major milestone with the approval of VYKAT XR (diazoxide choline) , making it the first FDA-approved Prader-Willi syndrome drug for hyperphagia
The Challenge of Bioavailability While the science behind this combination is strong, there is a major hurdle: absorption
Common Blood Tests and Hormone Panels While no test confirms perimenopause alone, several blood tests help paint a clearer picture and rule out other conditions
Market totals for telehealth GLP-1 range roughly $200 to $700+ monthly as of April 2026
Hypoglycemia opens up new horizons Both Samols and Marks were interested in hypoglycaemia, a condition common among diabetics, patients with acute or chronic liver failure and a rare form of pancreatic tumour called 'insulinoma' which leads to the overproduction of insulin
If hormone balance might be a factor in your energy or weight concerns, options like BioTE Bioidentical Hormone Replacement Therapy may also be worth exploring alongside your injection protocol